NASDAQ$LMAT

LeMaitre Vascular Inc · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

LeMaitre Vascular reported a decrease in sales and net income due to the COVID-19 pandemic, while operating margin remained strong and the acquisition of Artegraft was completed.

LeMaitre Vascular's Q2 2020 sales decreased by 16% compared to Q2 2019, with a net income decline of 24%. However, the company maintained a solid operating margin of 20% and completed the acquisition of Artegraft.

  • Sales decreased by 16% year-over-year, with a 24% organic decline.
  • Operating income decreased by 18%, but adjusted operating income increased by 3% excluding acquisition-related special items.
  • Net income decreased by 24%, with earnings per diluted share down by 25%.
  • The company acquired Artegraft for $90.0 million on June 22, 2020.

Headline financials

Total Revenue

$24.9M

Previous: $29.5M-15.7%
EPS (adj)

$0.17

Previous: $0.23-26.1%
Operating Margin

20.0%

No prior period
Free Cash Flow

$3.5M

Previous: $4.62M-24.3%
Net Income

$3.5M

Previous: $4.62M-24.3%
Operating Income

$4.87M

Previous: $5.92M-17.6%
Gross Profit

$17M

Previous: $20.3M-16.2%
Cash & Equivalents

$20M

Previous: $13.3M+50.6%
Total Assets

$256M

Previous: $163M+57.2%
Stock-Based Comp

$803K

Previous: $694K+15.7%

Revenue & EPS history

LeMaitre Vascular · Revenue · Quarterly

$24.9M

Q2 2020-15.7%vs Q2 2019
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Forward guidance

Due to COVID-19 uncertainties, guidance is limited to Q3 2020, projecting sales of $30.5mm - $34.5mm, operating income of $5.3mm - $7.8mm, and EPS of $0.17 - $0.26.

Tailwinds

  • Projected Q3 2020 sales between $30.5 million and $34.5 million (Midpoint:+12%).
  • Projected Q3 2020 operating income between $5.3 million and $7.8 million (Midpoint:+11%).

Headwinds

  • Projected Q3 2020 EPS between $0.17 and $0.26 (Midpoint: -15%).
  • Uncertainties driven by the COVID-19 pandemic limit financial guidance to Q3 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+1.2%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.5%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+24.3%

Q1 2017

Best reaction

-22.1%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.6%-9.3%-15.7%
Q4 2025+24.2%+18.0%+16.7%
Q3 2025+1.4%+5.1%-1.2%
Q1 2025-13.0%-9.6%-8.9%
Q4 2024-8.1%-12.9%-16.9%
Q3 2024+6.5%+10.8%+20.1%
Q2 2024-2.2%-5.8%+3.9%
Q1 2024+11.1%+13.7%+18.1%
Q4 2023+15.2%+9.5%+7.6%
Q3 2023-4.0%+1.3%+10.8%
Q2 2023+2.3%-10.1%-8.6%
Q1 2023+15.4%+23.6%+17.1%
Q4 2022+6.2%+3.7%+5.2%
Q3 2022-19.6%-17.4%-11.5%
Q2 2022+4.7%+7.1%+3.8%
Q1 2022-2.9%-0.2%+2.6%
Q4 2021+6.2%+9.1%+3.0%
Q3 2021-5.2%-3.9%-11.2%
Q2 2021-0.5%+2.3%+2.9%
Q1 2021-2.8%-4.9%-5.1%
Q4 2020+7.8%+7.8%-2.0%
Q3 2020-1.7%+5.6%+19.8%
Q2 2020+13.3%+4.4%+3.9%
Q1 2020-14.1%-14.9%-12.4%
Q4 2019-20.1%-20.0%-23.6%
Q3 2019-1.5%+0.8%+1.8%
Q2 2019+0.8%+1.0%-4.4%
Q1 2019-8.2%-4.1%-10.6%
Q4 2018+22.3%+18.0%+24.3%
Q3 2018-22.1%-27.3%-25.8%
Q2 2018-7.1%-3.6%-4.5%
Q1 2018-16.6%-18.9%-16.2%
Q4 2017+1.6%+0.4%+0.9%
Q3 2017-17.7%-15.7%-8.2%
Q2 2017+17.4%+19.2%+17.9%
Q1 2017+24.3%+18.5%+17.9%
Q4 2016-6.9%-6.8%+1.3%
Q3 2016+9.4%+8.6%+24.9%
Q2 2016+15.1%+24.1%+21.4%
Q1 2016-1.4%
Q4 2015+18.5%
Q3 2015+11.0%
Q2 2015+14.0%
Q1 2015+0.0%
Q4 2014+2.2%
Q3 2014+3.0%
Q2 2014+3.5%
Q1 2014+4.6%
Q4 2013-2.2%
Q3 2013-1.4%
Q2 2013+1.2%
Q1 2013+1.5%
Q4 2012+3.3%
Q3 2012-0.6%
Q2 2012+1.6%
Q1 2012+0.3%
Q4 2009-1.2%
Q4 2011-1.2%
Q3 2010-1.9%
Q3 2011-1.9%
Q4 2010+0.1%
Q2 2011+0.1%
Q2 2010+0.1%
Q1 2011-1.1%
Q1 2010-3.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro